Copyright
©The Author(s) 2015.
World J Gastrointest Surg. Apr 27, 2015; 7(4): 52-59
Published online Apr 27, 2015. doi: 10.4240/wjgs.v7.i4.52
Published online Apr 27, 2015. doi: 10.4240/wjgs.v7.i4.52
Table 1 Patient characteristics and procedure specifications
Age | Sex | Diagnosis | No. of RF applications/session | No of sessions | Dead/alive |
5 Watts | |||||
82 | F | Mucinous cyst | 3 | 1 | Alive |
73 | F | Mucinous cyst | 5 | 1 | Alive |
46 | F | Microcystic adenoma | 5 | 1 | Alive |
15 Watts | |||||
40 | F | Mucinous cyst | 3 | 1 | Alive |
27 | F | Mucinous cyst | 2 | 1 | Alive |
20 Watts | |||||
57 | F | NET | 6 | 1 | Alive |
82 | F | NET | 4 | 2 | Alive |
25 Watts | |||||
78 | M | IPMN | 7 | 1 | Alive |
- Citation: Pai M, Habib N, Senturk H, Lakhtakia S, Reddy N, Cicinnati VR, Kaba I, Beckebaum S, Drymousis P, Kahaleh M, Brugge W. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg 2015; 7(4): 52-59
- URL: https://www.wjgnet.com/1948-9366/full/v7/i4/52.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v7.i4.52